EMEA-001965-PIP01-16
Key facts
| Invented name |
|
| Active substance |
Olodaterol (hydrochloride)
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0112/2017
|
| PIP number |
EMEA-001965-PIP01-16
|
| Pharmaceutical form(s) |
Inhalation solution
|
| Condition(s) / indication(s) |
Treatment of cystic fibrosis
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Boehringer Ingelheim International GmbH
Germany
E-mail: paediatrics@boehringer-ingelheim.com Tel.: +49 6132778271 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|